ArticleInfection and drug resistance2021

Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.

Angela Chiereghin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.